Met Life Investment Management, LLC Ionis Pharmaceuticals Inc Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 9,160 shares of IONS stock, worth $265,914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,160
Previous 9,363
2.17%
Holding current value
$265,914
Previous $375,000
14.67%
% of portfolio
0.0%
Previous 0.0%
Shares
41 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
131MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$478 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$411 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$333 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$300 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$228 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.12B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...